Shopping Cart
- Remove All
Your shopping cart is currently empty
Imirestat (HOE 843) is an aldose reductase inhibitor that can be used in diabetes research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $30 | In Stock | |
| 5 mg | $48 | In Stock | |
| 10 mg | $75 | In Stock | |
| 25 mg | $151 | In Stock | |
| 50 mg | $243 | In Stock | |
| 100 mg | $389 | In Stock | |
| 200 mg | $553 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $52 | In Stock |
| Description | Imirestat (HOE 843) is an aldose reductase inhibitor that can be used in diabetes research. |
| In vivo | Administration of 1 mg/kg Imirestat increased nerve conduction velocity, however, had no effect on resistance to hypoxic conduction block or deficits in insulin-stimulated Uban-sensitive ATPase activity[1]. |
| Synonyms | HOE 843, Alcon 1576, AL 1576 |
| Molecular Weight | 286.23 |
| Formula | C15H8F2N2O2 |
| Cas No. | 89391-50-4 |
| Smiles | Fc1ccc2-c3ccc(F)cc3C3(NC(=O)NC3=O)c2c1 |
| Relative Density. | 1.58g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (349.37 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (13.97 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.